Virtu KCG Holdings’s Fortress Biotech FBIO Stock Holding History

Virtu KCG Holdings’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,389	Closed	-$188K	–	3048
2017 Q1	$188K	Buy	+3,389	New	+$152K	0.01%	2465
2016 Q2	–	Sell	-727	Closed	-$34K	–	3047
2016 Q1	$34K	Sell	727 -800	-52%	-$33.8K	﹤0.01%	2524
2015 Q4	$64K	Buy	1,527 +286	+23%	+$12K	﹤0.01%	3110
2015 Q3	$48K	Sell	1,241 -4,138	-77%	-$193K	﹤0.01%	3002
2015 Q2	$271K	Buy	5,379 +511	+10%	+$26.2K	﹤0.01%	2200
2015 Q1	$281K	Buy	+4,868	New	+$203K	0.01%	1987
2014 Q3	–	Sell	-2,308	Closed	-$60K	–	3714
2014 Q2	$60K	Sell	2,308 -1,515	-40%	-$39.9K	﹤0.01%	3405
2014 Q1	$114K	Buy	3,823 +149	+4%	+$5.81K	﹤0.01%	3174
2013 Q4	$144K	Buy	3,674 +2,746	+296%	+$106K	﹤0.01%	3291
2013 Q3	$98K	Buy	+928	New	+$114K	﹤0.01%	3373

Other funds holding FBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AHB

Abner Herrman & Brock Jersey City, New Jersey $1.05B AUM 42.66% 1-Year Est. Return

Virtu KCG Holdings's FBIO Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Fortress Biotech (FBIO) in Q2 2017, closing a stake of 3,389 shares — an estimated $188K sold.

Virtu KCG Holdings first reported a position in FBIO in Q3 2013 and held it in 10 quarters. The position peaked at $281K in Q1 2015. 54 funds tracked by Wall St. Rank hold FBIO as of Q2 2017.

Virtu KCG Holdings reported no remaining Fortress Biotech position as of Q2 2017 after selling out during the quarter.
Virtu KCG Holdings sold 3,389 Fortress Biotech shares in Q2 2017, an estimated $188K.
Virtu KCG Holdings first reported a position in Fortress Biotech in Q3 2013 and held it in 10 quarters.
Virtu KCG Holdings's Fortress Biotech position peaked at $281K in Q1 2015.
54 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.